Dark chocolate and vascular function in patients with peripheral artery disease: A randomized, controlled cross-over trial

被引:12
|
作者
Hammer, Alexandra [1 ]
Koppensteiner, Renate [1 ]
Steiner, Sabine [1 ]
Niessner, Alexander [2 ]
Goliasch, Georg [2 ]
Gschwandtner, Michael [1 ]
Hoke, Matthias [1 ]
机构
[1] Med Univ Vienna, Dept Internal Med 2, Div Angiol, A-1090 Vienna, Austria
[2] Med Univ Vienna, Dept Internal Med 2, Div Cardiol, A-1090 Vienna, Austria
关键词
Dark chocolate; vascular function; peripheral artery disease; flow-mediated dilatation; laser Doppler fluxmetry; ENDOTHELIUM-DEPENDENT VASODILATION; CARDIOVASCULAR RISK-FACTORS; BLOOD-PRESSURE; NITRIC-OXIDE; COCOA INTAKE; DYSFUNCTION; RICH; RESISTANCE; ASSOCIATION; SMOKING;
D O I
10.3233/CH-141817
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Flavonoid-rich dark chocolate has positive effects on vascular function in healthy subjects and in patients at risk of atherosclerosis. The impact of dark chocolate on endothelial and microvascular function in patients with symptomatic peripheral artery disease (PAD) has not been investigated so far. In an investigator blinded, randomized, controlled, cross-over trial we assessed the effect of flavonoid-rich dark chocolate and cocoa-free control chocolate on flow-mediated dilatation (FMD) of the brachial artery and on microvascular function (assessed by Laser Doppler fluxmetry) in 21 patients with symptomatic (Fontaine stage II) PAD. Measurements were done in each patient on 2 single days, with an interval of 7 days, at baseline and at 2 hours after ingestion of 50 g dark chocolate or 50 g white chocolate, respectively. FMD remained unchanged after intake of dark chocolate (baseline and 2 hours after ingestion, %: 5.1 [IQR 4.4 to 7.3] and 5.5 [IQR 3.9 to 10.4]; p = 0.57, and after intake of white chocolate (baseline and 2 hours after ingestion, %: 6.4 [IQR 4.5 to 11.4] and 4.4 [IQR 2.6 to 8.7]; p = 0.14. Similarly, microcirculatory parameters were not significantly altered after intake of any chocolate compared with the respective baseline values. In conclusion, a single consumption of 50 g dark chocolate has no effect on endothelial and microvascular function in patients with symptomatic PAD.
引用
收藏
页码:145 / 153
页数:9
相关论文
共 50 条
  • [1] Effect of almond consumption on vascular function in patients with coronary artery disease: a randomized, controlled, cross-over trial
    Chen, C-Y. Oliver
    Holbrook, Monika
    Duess, Mai-Ann
    Dohadwala, Mustali M.
    Hamburg, Naomi M.
    Asztalos, Bela F.
    Milbury, Paul E.
    Blumberg, Jeffrey B.
    Vita, Joseph A.
    NUTRITION JOURNAL, 2015, 14
  • [2] Effect of almond consumption on vascular function in patients with coronary artery disease: a randomized, controlled, cross-over trial
    C-Y. Oliver Chen
    Monika Holbrook
    Mai-Ann Duess
    Mustali M Dohadwala
    Naomi M Hamburg
    Bela F. Asztalos
    Paul E. Milbury
    Jeffrey B. Blumberg
    Joseph A. Vita
    Nutrition Journal, 14
  • [3] Genistein in Sanfilippo Disease: A Randomized Controlled Cross-over Trial
    de Ruijter, Jessica
    Valstar, Marlies
    Kulik, Wim
    Wijburg, Frits
    Wegrzyn, Grzegorz
    MOLECULAR GENETICS AND METABOLISM, 2012, 105 (02) : S26 - S26
  • [4] No effect of resveratrol in patients with mitochondrial myopathy: A cross-over randomized controlled trial
    Lokken, Nicoline
    Khawajazada, Tahmina
    Storgaard, Jesper Helbo
    Raaschou-Pedersen, Daniel
    Christensen, Maja Elling
    Hornsyld, Tessa Munkeboe
    Krag, Thomas
    Orngreen, Mette C.
    Vissing, John
    JOURNAL OF INHERITED METABOLIC DISEASE, 2021, 44 (05) : 1186 - 1198
  • [5] EFFECTS OF RESISTANCE TRAINING ON CARDIOVASCULAR FUNCTION IN PATIENTS WITH PERIPHERAL ARTERY DISEASE: A RANDOMIZED CONTROLLED TRIAL
    Gomes, Ana P. F.
    Correia, Marilia A.
    Soares, Antonio H. G.
    Cucato, Gabriel G.
    Lima, Aluisio H. R. A.
    Cavalcante, Bruno R.
    Sobral-Filho, Dario C.
    Ritti-Dias, Raphael M.
    JOURNAL OF STRENGTH AND CONDITIONING RESEARCH, 2018, 32 (04) : 1072 - 1080
  • [6] Effect of 5 weeks of oral acetazolamide on patients with pulmonary vascular disease: A randomized, doubleblind, cross-over trial
    Lichtblau, M.
    Saxer, S.
    Mueller, J.
    Appenzeller, P.
    Berlier, C.
    Schneider, S. R.
    Mayer, L.
    Furian, M.
    Schwarz, E. I.
    Swenson, E. R.
    Bloch, K. E.
    Ulrich, S.
    PULMONOLOGY, 2024, 30 (04): : 362 - 369
  • [7] Dark Chocolate Acutely Improves Walking Autonomy in Patients With Peripheral Artery Disease
    Loffredo, Lorenzo
    Perri, Ludovica
    Catasca, Elisa
    Pignatelli, Pasquale
    Brancorsini, Monica
    Nocella, Cristina
    De Falco, Elena
    Bartimoccia, Simona
    Frati, Giacomo
    Carnevale, Roberto
    Violi, Francesco
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2014, 3 (04):
  • [8] Almonds and Biomarkers of Lipid Peroxidation: A Randomized Controlled Cross-over Trial
    Josse, Andrea R.
    Kendall, Cyril W. C.
    Marchie, Augustine
    Nguyen, Tri H.
    Blumberg, Jeffrey B.
    Lapsley, Karen G.
    Jenkins, David J. A.
    FASEB JOURNAL, 2008, 22
  • [9] The effect of high altitude (2500m) on incremental cycling exercise in patients with pulmonary vascular disease. A randomized controlled cross-over trial
    Mueller, Julian
    Schneider, Simon R.
    Bauer, Meret
    Mayer, Laura
    Lueoend, Lea
    Ulrich, Tanja
    Furian, Michael
    Forrer, Aglaia
    Schwarz, Esther I.
    Bloch, Konrad E.
    Lichtblau, Mona
    Ulrich, Silvia
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [10] A randomized, placebo-controlled trial of canakinumab in patients with peripheral artery disease
    Russell, Kerry S.
    Yates, Denise P.
    Kramer, Christopher M.
    Feller, Andrea
    Mahling, Ping
    Colin, Laurence
    Clough, Timothy
    Wang, Tianke
    LaPerna, Lucy
    Patel, Alpa
    Lawall, Holger
    Shennak, Mustafa M.
    Fulmer, James
    Nikol, Sigrid
    Smith, William B.
    Mueller, Oliver J.
    Ratchford, Elizabeth, V
    Basson, Craig T.
    VASCULAR MEDICINE, 2019, 24 (05) : 414 - 421